ESR2 and cancer: ERα and ERβ activation. On the basis of evidence that atrazine influences the development of estrogen-sensitive tumors (Cooper et al. 2007), we first evaluated whether atrazine could activate a transiently transfected ER reporter gene in estrogen-sensitive ovarian BG-1, breast MCF-7, and endometrial Ishikawa cancer cells.